Fierce Pharma

MAY 9, 2024

A BIO survey of biopharma companies indicated that a sudden break-off from Chinese CDMOs could harm millions of patients. Innovent Biologics' GLP-1R/GCGR dual agonist, licensed from Eli Lilly, has notched a second positive phase 3 rea | Takeda launched a restructuring to achieve “organizational simplicity.” And more.

Biopharma 130

Biopharma Pharma Patients 130

pharmaphorum

DECEMBER 18, 2022

Science has taken a vertical growth trajectory, yet such innovations are, at best, slow to reach the patients in need. We believe that innovation in patient access models is the necessary catalyst to aid patients in starting on and staying on the therapies they need to improve their lives.

Biopharma 98

Biopharma Patients Prescription Medical 98

PM360

FEBRUARY 1, 2024

Embarking on the journey from product development to market success in the biopharma industry is no small feat. According to a McKinsey report , a startling 40% of biopharma products fail to meet their sales forecasts within the initial two years, prompting a critical reassessment of strategies for product launches.

Biopharma 59

Biopharma Competition Prescription Marketing 59

European Pharmaceutical Review

DECEMBER 20, 2023

1 The changes form part of the 2020 Pharmaceutical Strategy for Europe will impact pharma and biopharma companies operating in Europe. The second is an adjustment of unmet need categorisation required for RDP extension; unmet need definition now encompasses ‘meaningful’ impact patient outcomes (notably including quality of life).

Biopharma 98

Biopharma Pharmaceutical Medicine Manufacturing 98

Pharmaceutical Commerce

AUGUST 8, 2024

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

Distribution 104

Distribution Biopharma Marketing Pharma 104

Pharmaceutical Commerce

JUNE 17, 2024

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

Distribution 103

Distribution Biopharma Pharma Patients 103

Pharmaceutical Technology

SEPTEMBER 8, 2022

We have focused on PD-1-IL-2 as a biology that has great potential for benefiting patients.”. The post Roche to acquire biopharma firm Good Therapeutics for $250m appeared first on Pharmaceutical Technology. Subject to necessary clearance, the acquisition is anticipated to conclude in the third quarter of this year.

Biopharma 111

Biopharma Manufacturing Patients Pharma 111

European Pharmaceutical Review

AUGUST 24, 2023

This strategy shift did not occur overnight, but evolved in response to the changing biopharma landscape. Even among the leaders of the biopharma sector, few companies have a significant presence across these platforms, Baral highlighted. Venture funding in 2022 came in at about $13.7 billion, down from the high of 2021.

Biopharma 98

Biopharma Pharmaceutical Pharma Medical 98

PM360

APRIL 22, 2024

This is especially relevant in biopharmaceutical patient engagement, where regulatory infractions can have existential consequences. The Unique Challenges of Patient/Pharma Interaction Patient engagement has become a critical component of medical marketing.

Patients 52

Patients Biopharma Ethics Marketing 52

MedCity News

AUGUST 12, 2024

FDA approval of Ascendis Pharma’s Yorvipath is just in time for patients with hypoparathyroidism as Takeda Pharmaceutical will soon stop making the only drug therapy for the rare disorder. The post Ascendis Pharma Lands Long-Awaited FDA Drug Approval in Rare Hormone Deficiency appeared first on MedCity News.

FDA 116

FDA Pharma Competition Pharmaceutical 116

MedCity News

OCTOBER 27, 2023

Technology is transforming how clinical trials are run. A panel during MedCity News’ INVEST Digital Health conference discussed the tech trends shaping the design and execution of drug studies.

Biopharma 120

Biopharma Patients Pharma 120

Pharmaceutical Technology

MARCH 22, 2023

The appeal of process intensification continues to grow in the biopharma industry as a means of not only increasing the productivity, but also improving sustainability. Patients living with cancer and Alzheimer’s are two examples of groups that need access. Yet this is far from straightforward. Download to learn more.

Biopharma 52

Biopharma Manufacturing Engineering Specialization 52

MedCity News

JUNE 27, 2024

Verona Pharma’s COPD drug Ohtuvayre is a single small molecule that blocks two targets to bring patients both bronchodilation and anti-inflammatory effects. The post Verona Pharma Drug With Dual Mechanism Lands FDA Approval in COPD appeared first on MedCity News.

Pharma 109

Pharma FDA Medical Patients 109

pharmaphorum

JUNE 27, 2022

The bolt-on deal comes shortly after Ipsen announced plans to sell its consumer health business for around €350 million, leaving it as a pure-play prescription pharma operating in the cancer, rare diseases and neuroscience categories. The post Ipsen beefs up in oncology, buying US biopharma Epizyme appeared first on.

Biopharma 110

Biopharma Sales Prescription FDA 110

European Pharmaceutical Review

NOVEMBER 16, 2022

For young biotechs, scaling up production brings green-field challenges, while for more established pharma a shift may be required to ensure that facilities are optimised for new ways of working. That is because of the relative expense of emerging therapies and the pressure on pricing for continuing product lines.

Manufacturing 119

Manufacturing Pharma Biopharma Management 119

Fierce Pharma

SEPTEMBER 19, 2023

With the right infrastructure, intelligent tools stand to not only process data but also improve clinical decision-making—helping find more patients for biopharma companies, and faster, too. Especially with the proliferation of AI in other industries and chatGPT.

Biopharma 216

Biopharma Healthcare Healthcare Patients 216

pharmaphorum

AUGUST 5, 2022

Over the past 15 years, more than 60% of asset growth among the top 30 biopharma companies came from acquisitions. The pace of innovation in biopharma has rocketed over the last two years, with vaccines, new antivirals, and therapies delivered at an unprecedented pace. About the Author.

Biopharma 52

Biopharma Marketing Pharma Relationship management 52

MedCity News

MARCH 18, 2024

As GenAI and other technologies advance the speed of development and the precision of drugs, pharma commercial teams need to make sure they are harvesting the right data with the right AI tools in order to ultimately reach the right patients.

Pharma 113

Pharma Marketing Sales Patients 113

PM360

AUGUST 9, 2022

Biopharma blockbusters in the last 10 years show a disturbing trend. As a top 10 biopharma company leader shared with us, “Real blockbusters are gone. For biopharma, success in this space will require integrated models that are significantly different than what has been used with historic medicines. In oncology, it’s 47% less.

Biopharma 69

Biopharma Marketing Healthcare Healthcare 69

MedCity News

NOVEMBER 22, 2024

A patient death in a clinical trial usually prompts the FDA to impose a clinical hold. The post Patient Dies in Gene Therapy Trial, But FDA Permits Neurogene to Proceed With Low Dose appeared first on MedCity News.

FDA 107

FDA Patients Biopharma Pharma 107

Pharma Marketing Network

MARCH 25, 2022

Although the caregiver is seen as an extension of the patient and their role is not strictly defined, they are informal members of the front-line care team. 5 While the CDC gathers information on these topics for public health planning, there are immediate needs that pharma can address. . What Can Pharma Do? Sunny White.

Pharma 98

Pharma Education Training Transportation 98

Clarivate

MAY 8, 2024

Doubling down on strategic therapeutic areas Pharma once again finds itself having to narrow its sights on partnerships that deliver the next blockbuster and enable differentiation from the competition—all while navigating increasing regulatory scrutiny and shifting patient and payer expectations.

Pharma 59

Pharma Biopharma Prospecting Competition 59

pharmaphorum

NOVEMBER 28, 2022

Amidst all this, Adelphi Group’s CEO Stuart Cooper found a moment to sit with pharmaphorum web editor Nicole Raleigh and discuss just how exciting it was to bring to vibrant and discursive life the ethos of Anthropy – a united vision for British business, including pharma, and the future of this nation overall.

Pharma 98

Pharma Biopharma Recruitment Management 98

pharmaphorum

JANUARY 9, 2023

Biopharma and healthcare group Chiesi Farmaceutici S.p.A. is to acquire the 2015-established Amryt Pharma Plc. He continued: “Amryt has steadily brought innovative products to new markets and, by adding them to the Chiesi portfolio, we hope to make them available to even more patients who may require them.”. on 6 th January.

Pharma 98

Pharma Biopharma Management Medicine 98

European Pharmaceutical Review

AUGUST 28, 2024

Novartis Pharma AG and biotech Lindy Biosciences have agreed to collaborate to advance subcutaneous biologic injectables. This platform enables high concentrations of biologics to be delivered in a single dose, improving the convenience of administration and patient and treatment compliance, according to Lindy Biosciences. percent).

Biopharma 110

Biopharma Medicine Patients Sales 110

Clarivate

MARCH 8, 2023

In recent years, there has been an increased focus on real world evidence to advance medical science and improve patient quality of life. Biopharma companies are investing in the use of real world data (RWD) to accelerate innovation. The treatment of patients experiencing acute disease is quite dynamic.

Patients 59

Patients Biopharma Medical science Electronics 59

pharmaphorum

NOVEMBER 24, 2022

Mirati Therapeutics is the subject of takeover speculation in the biopharma sector once again, as it waits for the FDA’s decision on its KRAS inhibitor adagrasib in non-small cell lung cancer (NSCLC). Response rates above 50% in PD-1 high/intermediate patients with no liver tox surprises could set up for a potential acquisition.”

Pharma 105

Pharma Biopharma FDA Competition 105

MedCity News

NOVEMBER 10, 2024

The post Driving Genetic Testing Adoption and Improved Patient Care through Health Data Intelligence appeared first on MedCity News.

Patients 114

Patients Medicine Healthcare Healthcare 114

MedCity News

JULY 6, 2022

Emergn Principal Consultant Mario Moreira shared insights on how pharma companies can use the principles of Value, Flow and Quality to shorten drug development timelines and deliver better patient outcomes through improved ways of working.

Pharma 123

Pharma Consulting Patients Manufacturing 123

pharmaphorum

OCTOBER 11, 2022

The Reuters Pharma event 2022 began as a bustling industry affair yesterday, based out of the Nice Acropolis convention centre on France’s balmy south coast. The onus, he said, was on pharma to listen now. Patient engagement – what history teaches us about pharma’s future evolution. A one-on-one approach.

Pharma 98

Pharma Patients Medicine Healthcare 98

MedCity News

SEPTEMBER 4, 2024

Eli Lilly now offers vials of obesity medication Zepbound directly to self-pay patients at a nearly 50% discount off the drug’s list price. But more than offering patients a lower-cost alternative, this move represents a strategic stance against certain pharmaceutical industry players.

Patients 123

Patients Medical Pharmaceutical Biopharma 123

MedCity News

FEBRUARY 23, 2023

FDA approval of Sanofi hemophilia A drug Altuviiio provides patients with a therapeutic option that lasts longer than most other products available, including one already marketed by the French pharma giant. Altuviiio also gives Sanofi a way to better compete against blockbuster Roche drug Hemlibra.

Competition 106

Competition FDA Patients Pharma 106

MedCity News

DECEMBER 28, 2022

It fits in amongst the goal of running nimble and patient-centered studies. But, without legislation, it’s doubtful that pharma companies will give up ownership of participant data out of sheer goodwill. Putting data into the hands of participants is an important step in changing the traditional clinical trial paradigm.

Patients 102

Patients Pharma Biopharma 102

MedCity News

FEBRUARY 14, 2024

2024 presents an exciting yet challenging landscape for global pharma marketers.

Marketing 105

Marketing Pharma Pharmaceutical Patients 105

Clarivate

JUNE 29, 2023

We’re mindful of some challenges that life science and healthcare organizations must work through before this technology is mature enough for use in critical business decisions that may impact patient health. Our customers entrust our products and services to help them improve patient health, and we will not jeopardize that mission.

Patients 98

Patients Safety Healthcare Healthcare 98

European Pharmaceutical Review

JUNE 28, 2024

Data integrity and AI: how pharma can build a data-driven future LabVantage Solutions explains that data integrity remains a core responsibility – and challenge – as pharmaceutical organisations seek to leverage AI and data lakes to grow, innovate and serve patients.

Biopharma 52

Biopharma Manufacturing Safety Pharmaceutical 52

PharmaVoice

OCTOBER 27, 2023

With a knack for melding science and patient-focused marketing techniques, the CEO of the biopharma commercial unit at Sumitomo Pharma America has notched blockbuster successes throughout her career.

Biopharma 52

Biopharma Pharma Marketing Patients 52